- Research
- Open access
- Published:
Non-exclusive breastfeeding is associated with pneumonia and asthma in under-five children: an umbrella review of systematic review and meta-analysis
International Breastfeeding Journal volume 20, Article number: 18 (2025)
Abstract
Background
Despite numerous reviews examining the impact of exclusive breastfeeding on preventing childhood pneumonia and asthma, a comprehensive and up-to-date synthesis is lacking. This umbrella review aims to consolidate the current evidence on the link between non-exclusive breastfeeding and the risk of pneumonia and asthma in under-five children.
Methods
A comprehensive search was conducted in PubMed, Embase, Scopus, Web of Science, the Cochrane Database of Systematic Reviews, and Google Scholar to identify systematic review and meta-analysis (SRM) studies evaluating the effect of exclusive breastfeeding on preventing childhood pneumonia and asthma globally. The latest search was conducted on January 25/2025. The quality of the included studies was assessed using the Assessment of Multiple Systematic Reviews Two (AMSTAR-2) tool. A weighted inverse variance random-effects model was employed to generate pooled estimates. Summary effect estimates were expressed using odds ratios (OR) with 95% confidence intervals (CI). We evaluated the quality of evidence for each association using the Grading of Recommendations, Assessment, Development, and Evaluations (GRADE) framework, categorising it as convincing (class I), highly suggestive (class II), suggestive (class III), and weak (class IV).
Results
Twelve SRMs, including 270 primary studies with over ten million participants, were analysed. The random-effects model revealed a highly suggestive association between non-exclusive breastfeeding and an increase in the risk of pneumonia (OR 2.34; 95% CI 1.89, 2.78, GRADE: highly suggestive). Similarly, there was highly suggestive evidence that non-exclusive breastfeeding was associated with a 29% higher risk of childhood asthma (OR 1.21; 95% CI 1.07, 1.34, GRADE: highly suggestive).
Conclusion
Our results highlighted that non-exclusive breastfeeding is associated with an increased risk of pneumonia and asthma in under-five children. These findings emphasise the critical role of exclusive breastfeeding in reducing the risk of respiratory health issues, highlighting the need for policies and initiatives that promote breastfeeding as a key strategy for improving children’s health outcomes.
Background
Respiratory diseases, including childhood pneumonia and asthma, remain significant causes of mortality and morbidity among under-five children worldwide [1,2,3,4]. Despite a decline in global mortality rates, these conditions continue to represent a substantial health burden [5]. In 2019, pneumonia accounted for 45 million global episodes among under-five children and resulted in over 700,000 deaths, making it the leading cause of mortality in this age group [6]. Childhood asthma also contributed considerably, with 12,900 deaths and 5.1 million new cases reported globally in 2019 [7].
Researchers have identified numerous early factors that influence the likelihood of childhood pneumonia and asthma [8,9,10,11]. Exclusive breastfeeding is a critical protective factor, providing several mechanisms that reduce the risk of these conditions [12, 13]. Breast milk contains immunoglobulins, particularly IgA, which coat the mucosal surfaces of the respiratory tract, offering direct protection against pathogens [14]. Additionally, breastfeeding supports the establishment of a healthy gut microbiome, which plays a vital role in modulating the immune response and reducing systemic inflammation [15]. The presence of anti-inflammatory cytokines and bioactive components in breast milk further enhances the infant’s immune system, reducing susceptibility to respiratory infections and inflammation associated with asthma [16].
To date, more than 270 primary studies and numerous systematic reviews and meta-analyses, have investigated the impact of exclusive breastfeeding on the risk of childhood pneumonia and asthma in children under five [11, 17,18,19,20,21,22,23,24,25,26]. Despite this substantial body of evidence, an up-to-date comprehensive review is lacking to inform the development of current prevention strategies, as most existing reviews are over a decade old. Additionally, findings from available meta-analyses have been inconsistent. For example, a 2020 meta-analysis by Karmany et al. reported a fourfold increase in the risk of pneumonia among non-exclusively breastfed children [20]. In contrast, meta-analyses by Brew et al. suggested that non-exclusive breastfeeding was not associated with an increased risk of childhood asthma [22]. This umbrella review aims to consolidate the findings from existing systematic reviews and meta-analyses, provide the most current evidence, and offer practical recommendations for researchers, clinicians, and policymakers based on the synthesised results.
Methods
Research design
This umbrella review was conducted following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) recommendations [27]. A predefined protocol guided the search, selection, data extraction, and analysis of relevant articles. The protocol was registered with the International Prospective Register of Systematic Reviews (PROSPERO) (ID: CRD42025640880) [28]. To ensure the study’s quality, we also followed the PRIOR statement, a reporting guideline for overviews of reviews on healthcare interventions [29].
Searching strategy and information sources
Studies were identified through searches in PubMed, Embase, Web of Science, Google Scholar, and Scopus, focusing on Systematic Review and Meta-Analysis (SRM) studies that reported the effect of exclusive breastfeeding on preventing childhood pneumonia and asthma globally. The latest search was conducted on January 25/2025. The search strategy included MeSH terms, keywords, their combinations, and snowball searching of reference lists from articles identified in the database search to retrieve additional relevant studies. For each condition, five key concepts and search terms were developed: Concept 1 (Exclusive breastfeeding), Concept 2 (childhood pneumonia and asthma respiratory problems), Concept 3 (SRM): ‘meta-analysis,’ ‘systematic review,’ and ‘review,’ and Concept 4 (Children): ‘Under Five Children,’ ‘Childhood.
The literature search was conducted independently by two reviewers, with any discrepancies resolved through consensus. The search terms were used both independently and in combination, employing ‘OR’ and ‘AND’ operators. In addition to systematic database searches, article retrieval was supplemented by reviewing the reference lists of included studies and using the ‘cited by’ and ‘related articles’ features on PubMed.
Study selection/eligibility criteria
The retrieved articles were exported to EndNote reference management software (version 8) to remove duplicates. Two investigators (BBA and MA) independently screened the studies based on titles and abstracts before retrieving the full-text papers. Pre-specified inclusion criteria were then applied to further assess the full-text articles. Included studies were Systematic Reviews and Meta-Analyses (SRM) that reported the effect of exclusive breastfeeding on the prevention of childhood pneumonia and asthma. Only articles published in English and addressing the Population, Intervention, Control, and Outcome (PICO) framework in a global context were considered.
Population
Under five children.
Intervention
Exclusive breastfeeding.
Control
Non-exclusive breastfeeding.
Outcome
Childhood pneumonia and asthma.
To be considered a systematic review or meta-analysis, studies had to meet the following predefined criteria: (a) have a defined literature search strategy, (b) appraise the quality of included studies using a relevant tool, and (c) use a standard method to pool the study’s results and providing summary estimates. Studies were excluded for any of the following reasons: (a) failure to report the measures of interest for this study, (b) language other than English, and (c) narrative reviews, editorials, correspondence, abstracts, and methodological studies. The screening and selection process was conducted in two stages: first, title and abstract screening, followed by full-text review. Any disagreements were resolved through consensus discussions with other reviewers to ensure the final selection of studies for inclusion in the umbrella review.
Quality assessment
We used the AMSTAR-2 checklist to assess the quality and transparency of the included systematic reviews and meta-analyses. It evaluates 16 domains, including research question clarity, protocol registration, risk of bias, study selection, data extraction, funding sources, statistical methods, and addressing heterogeneity and publication bias [30,31,32]. Each review was rated as high, moderate, low, or critically low quality based on adherence to AMSTAR-2 criteria. Two independent reviewers assessed the quality of the included studies, with disagreements resolved through consensus or consultation with a third author as needed.
Data extraction
Data from the included Systematic Review and Meta-Analysis (SRM) studies were extracted using a standardized data abstraction form, developed in an Excel spreadsheet. For each SRM study, the following data were extracted: (a) identification details (first author’s last name, publication year), (b) number of primary studies included, (c) number of study participants, (d) effect size with 95% confidence intervals, and (e) types of respiratory diseases.
Statistical analysis
After data extraction using Microsoft Excel, the data were imported into STATA version 17.0 statistical software for further analysis. Both narrative and quantitative approaches were employed to summarise the estimates from the included reviews. Summary effect estimates were re-calculated using random-effects models to account for expected heterogeneity across studies. The effect estimates were expressed using odds ratios (OR) with 95% confidence intervals (CI). Heterogeneity among studies was assessed using Cochrane’s Q statistic (Chi-square), inverse variance (I²) statistic, and p-values [40]. An I² value of zero indicated homogeneity, while values of 25%, 50%, and 75% were considered low, moderate, and high heterogeneity, respectively [32, 33]. For heterogeneous data, we applied the DerSimonian-Laird random-effects model. To assess the impact of individual studies on the overall effect size, a leave-one-out sensitivity analysis was performed by sequentially excluding each study and recalculating the pooled effect estimates based on the remaining studies. Publication bias was assessed using a funnel plot and, more objectively, through Egger’s regression test [34].
Credibility/GRADE assessment of each pooled analysis
We used the GRADE system to assess the quality of evidence for each pooled analysis, classifying it as convincing, highly suggestive, suggestive, or weak [35]. GRADE evaluates five criteria: risk of bias, inconsistency, indirectness, imprecision, and publication bias, with evidence from observational studies initially rated as low quality. Downgrades occur based on high risk of bias, inconsistency (I² values), indirectness (multiple control comparisons), imprecision (wide confidence intervals or small sample size), and publication bias (significant Egger test p-value). Convincing associations (Class I) required a p-value < 10⁻⁶, over 1,000 participants, low-to-moderate heterogeneity (I² < 50%), a 95% prediction interval excluding the null, and no small-study bias. Highly suggestive associations (Class II) involved over 1,000 participants, a p-value < 10⁻⁶, and a 95% prediction interval excluding the null. Suggestive evidence (Class III) required over 1,000 participants and a p-value ≤ 0.001, while weak associations (Class IV) needed a p-value ≤ 0.05, with p > 0.05 considered non-significant [35].
Results
Study selection
A total of 4,607 studies were identified from different databases. After duplication was removed, 2,444 articles remained. Finally, 219 studies underwent full-text review, and 12 SRMs comprising 270 independent primary studies were included in the final analysis [11, 17,18,19,20,21,22,23,24,25,26, 36] (Fig. 1).
Characteristics of included studies
The characteristics of the included studies are presented in Table 1. Twelve SRMs, including 270 primary studies and over ten million participants, were included in the analyses. The number of studies included in each systematic review ranged from 9 [18] to 46 [25]. The effect of non-exclusive breastfeeding on the risk of pneumonia and asthma ranged from 1.1 (1.16, 1.02) [23] to 4.0 (2.75,5.81) [20]. Seven of the included reviews were conducted before 2020 [11, 17, 19, 23,24,25,26] while five reviews were conducted after 2020 [18, 20,21,22, 36].
Quality assessment
Based on AMSTAR-2 criteria, the majority of the SRMs (7 out of 12) [17,18,19, 21, 23, 24, 26] were assessed as low quality, while 5 out of 12 [11, 20, 22, 25, 36] were rated as high quality (Table S1). The five most common reasons why many included SRMs are rated as low quality based on the AMSTAR-2 checklist are: failure to register the protocol in PROSPERO [11, 17, 19,20,21, 23,24,25,26], lack of justification for excluded studies [17, 23], absence of an evaluation of the risk of bias in the meta-analysis [11, 17, 18, 21,22,23,24], insufficient explanation of heterogeneity [17,18,19, 26], and failure to assess publication bias [11, 18, 19, 21].
The effect of non-exclusive breastfeeding on the risk of childhood pneumonia and asthma
Of the twelve SRMs included, six examined the effect of non-exclusive breastfeeding on the risk of childhood pneumonia [11, 17, 19,20,21,22], while the other six focused on its impact on the risk of childhood asthma [18, 23,24,25,26, 36]. The random-effects model revealed a highly suggestive association between non-exclusive breastfeeding and an increase in the risk of pneumonia (OR 2.34; 95% CI 1.89; 2.78, GRADE: highly suggestive (Class II) (Fig. 2). Similarly, there was highly suggestive, that non-exclusive breastfeeding was associated with a 21% higher risk of childhood asthma (OR 1.21; 95% CI 1.07, 1.34, GRADE: highly suggestive) (Fig. 3).
Sensitivity analysis
The results of this sensitivity analysis showed that the findings were not dependent on a single study. The pooled estimated risk associated with non-exclusive breastfeeding ranged from 2.05 (95% CI 1.12, 2.98) [20] to 2.50 (95% CI 2.10, 2.90) [23] for pneumonia and from 1.26 (95% CI 1.12, 1.40) to 1.33 (95% CI 1.21, 1.44) [24] for asthma, following the exclusion of each included study during the sensitivity analysis (Table 2).
Publication bias
A funnel plot showed an asymmetrical distribution (Figure S1). The Egger’s regression test value was < 0.001, which indicated that, the presence of publication bias (Figure S2). To address this, a trim-and-fill analysis was performed, which imputed four additional studies (Figure S3).
Quality of evidence/credibility according to GRADE evidence assessment
Overall, the quality of evidence, as assessed using the GRADE framework, indicates a highly suggestive evidence for the pooled analysis of pneumonia and asthma. Both analyses were downgraded based on two criteria: (1) inconsistency/heterogeneity, with I² values of 77.28%, and P = 0.00 for asthma and 87.04% for pneumonia, both reflecting high heterogeneity (I² > 75%), and (2) publication bias, detected in both analyses (Egger test p = 0.0074 for asthma, p = 0.0007 for pneumonia). However, both analyses performed well in the other three GRADE criteria: (1) no serious indirectness, (2) no serious imprecision, and (3) risk of bias assessment, where 3/4 of the AMSTAR questions were answered “yes” and 1/4 were rated “unclear” or “no.” As a result, the overall certainty of evidence for both pneumonia and asthma remains highly suggestive (Class II) (Table S2).
Discussion
This umbrella review evaluated the effect of non-exclusive breastfeeding on the risk of respiratory diseases, specifically childhood pneumonia and asthma, on a global scale, drawing data from 12 SRMs. The analysis revealed that children who were not exclusively breastfed had a 2.34-fold higher risk of developing pneumonia and a 21% increased risk of experiencing childhood asthma.
Exclusive breastfeeding, which involves providing only breast milk to infants under 6 months, has a significant positive impact on a child’s immunity, growth, and development. It is associated with a reduced risk of childhood asthma, Sudden Infant Death Syndrome (SIDS), and other conditions, although multiple factors contribute to these outcomes [37, 38]. Research has consistently shown that exclusive breastfeeding lowers morbidity and mortality rates in children under five, as well as the risk of allergies and respiratory conditions due to the protective components in breast milk [39,40,41,42]. Not breastfeeding has been identified as a risk factor for acute respiratory infections, particularly pneumonia, which is a leading cause of hospitalization and death in children [11, 21, 43, 44]. Some of the included SRMs examined the impact of breastfeeding duration on child health outcomes, emphasising that longer durations of breastfeeding are associated with a significantly reduced risk of respiratory issues, such as asthma and pneumonia [24, 36]. Furthermore, some studies indicated that both exclusive and non-exclusive breastfeeding provide more substantial protection against respiratory health problems compared to non-breastfeeding, highlighting the health advantages of any form of breastfeeding over none [18, 19, 25]. This underscores the importance of promoting breastfeeding in all its forms as a key public health strategy to reduce the burden of childhood respiratory diseases.
Childhood pneumonia and asthma continue to be major causes of mortality and morbidity among under-five children worldwide. One of the Sustainable Development Goals (SDGs) is to reduce mortality in children under five, which can be achieved by improving child nutrition and preventing diseases. Several reviews suggest that exclusive breastfeeding can help prevent respiratory diseases, including pneumonia and asthma/wheezing, though the exact extent of this protective effect is not fully demonstrated in the literature [18, 20, 24, 45].
Breastfeeding is linked to a lower risk of respiratory problems through several physiological mechanisms. First, breast milk contains bioactive components like immunoglobulins (IgA), lactoferrin, and lysozyme, which strengthen the infant’s immune defences and reduce the risk of infections, such as pneumonia and bronchitis, that may lead to chronic respiratory issues [46, 47]. Second, breastfeeding promotes the development of the infant’s respiratory system, supporting optimal lung growth and function, which can enhance lung capacity and resilience to respiratory challenges [48, 49]. Third, the anti-inflammatory properties of breast milk help reduce airway inflammation, a key factor in respiratory conditions [50]. Finally, exclusive breastfeeding supports the development of the gut microbiome, which plays a crucial role in immune function and offers further protection against respiratory illnesses [51, 52].
Exclusive breastfeeding for the first six months is strongly recommended for its many benefits, including providing an ideal nutrient balance for growth, immune protection (particularly through colostrum), and support for digestive development [53, 54]. Longer exclusive breastfeeding is associated with a reduced risk of asthma and related complications. A dose-response effect was observed, with breastfeeding for 2–4 months reducing asthma outcomes by 64%, for 5–6 months by 61%, and for more than 6 months by 52%, compared to breastfeeding for less than 2 months [55].
The meta-analysis, which synthesizes data from eight published studies encompassing a total of 16,862 children and adolescents aged 7 to 15 years, suggests a positive association between longer durations of exclusive breastfeeding (specifically, more than 6 months) and higher cardiorespiratory fitness during childhood and adolescence [56]. This finding implies that extended breastfeeding may contribute to better cardiovascular health and physical endurance later in life. Furthermore, the analysis also highlights that respiratory problems may hurt cardiorespiratory fitness, indicating that children who experience respiratory issues may show diminished cardiorespiratory capacity [57]. These two findings suggest a potential link between breastfeeding duration, respiratory health, and overall physical fitness, which could inform future research on how early nutrition and health conditions interact to affect long-term fitness outcomes.
Strengths and limitations of the study
This umbrella review has several strengths. It draws from a wide range of data sources, including numerous systematic reviews and meta-analyses, providing a comprehensive analysis of exclusive breastfeeding’s effect on preventing pneumonia and asthma in children. The research adheres to PRISMA guidelines, ensuring high-quality, relevant studies, and uses the AMSTAR-2 tool for quality assessment. Subgroup analyses further enhance the study’s depth. Addressing a timely issue, we conducted multiple statistical tests to assess the evidence level, including contour-enhanced funnel plots, Egger’s regression tests, and the trim-and-fill technique, to evaluate publication bias and potential overstatement in the meta-analyses.
Despite its strengths, the study has several limitations. The included studies do not cover all countries, limiting the generalizability of the results. The high heterogeneity remained despite efforts to reduce it using a random-effects model and subgroup analysis. Missing data in some meta-analyses prevented the calculation of key metrics, such as small study effects and I², limiting our ability to fully evaluate the evidence. Additionally, observed heterogeneity may be influenced by sociocultural, economic, and political factors affecting vaccine hesitancy across regions. Future research, particularly cohort studies or RCTs, is needed to address residual confounding factors. Moreover, the majority of the included SRMs primarily focused on evaluating the impact of exclusive breastfeeding on the prevention of asthma and pneumonia in children under five. However, they did not provide sufficient insights on two key areas: (1) the effect of non-exclusive breastfeeding compared to no breastfeeding at all, and (2) the relationship between the duration of breastfeeding and child health outcomes. Therefore, future research should aim to assess the effects of both exclusive and non-exclusive breastfeeding, as well as the duration of breastfeeding, on various child health outcomes.
Conclusion
Our results highlight the increased risk of pneumonia and asthma associated with non-exclusive breastfeeding in children under five. These findings underscore the importance of breastfeeding as a critical strategy for reducing the incidence of respiratory health issues. These results support the existing recommendations for breastfeeding for at least six months since they are consistent with the theory that breastfeeding has a lasting protective impact against respiratory tract infections.
Data availability
No datasets were generated or analysed during the current study.
References
Zar HJ, Ferkol TW. The global burden of respiratory disease-impact on child health. Pediatr Pulmonol. 2014;49(5):430–4.
World Health Organization. Update in paediatric asthma 2024. Pediatr Respirol Crit Care Med. 2024;8(1):p3–10. https://doiorg.publicaciones.saludcastillayleon.es/10.4103/prcm.prcm_4_24. January-March 2024.
von Mutius E. The burden of childhood asthma. Arch Dis Child. 2000;82(suppl 2):ii2–5.
Le Roux DM. Childhood deaths due to pneumonia: a novel causal analysis of aetiology. Lancet Child Adolesc Health. 2024;8(3):178–9.
McAllister DA, Liu L, Shi T, Chu Y, Reed C, Burrows J, et al. Global, regional, and National estimates of pneumonia morbidity and mortality in children younger than 5 years between 2000 and 2015: a systematic analysis. Lancet Global Health. 2019;7(1):e47–57.
Kyu HH, Vongpradith A, Sirota SB, Novotney A, Troeger CE, Doxey MC, et al. Age–sex differences in the global burden of lower respiratory infections and risk factors, 1990–2019: results from the global burden of disease study 2019. Lancet Infect Dis. 2022;22(11):1626–47.
Zhang D, Zheng J. The burden of childhood asthma by age group, 1990–2019: A systematic analysis of global burden of disease 2019 data. Front Pediatr. 2022;10:823399.
Buelo A, McLean S, Julious S, Flores-Kim J, Bush A, Henderson J, et al. At-risk children with asthma (ARC): a systematic review. Thorax. 2018;73(9):813–24.
Bao Y, Chen Z, Liu E, Xiang L, Zhao D, Hong J. Risk factors in preschool children for predicting asthma during the preschool age and the early school age: a systematic review and meta-analysis. Curr Allergy Asthma Rep. 2017;17(12):85.
Phung DT, Wang Z, Rutherford S, Huang C, Chu C. Body mass index and risk of pneumonia: a systematic review and meta-analysis. Obes Rev. 2013;14(10):839–57. https://doiorg.publicaciones.saludcastillayleon.es/10.1111/obr.12055. Epub 2013 Jun 25. PMID: 23800284.
Jackson S, Mathews KH, Pulanić D, Falconer R, Rudan I, Campbell H, et al. Risk factors for severe acute lower respiratory infections in children– a systematic review and meta-analysis. Croatian Med J. 2013;54(2):110–21.
Alotiby AA. The role of breastfeeding as a protective factor against the development of the immune-mediated diseases: A systematic review. Front Pead. 2023;11:1086999.
Hossain S, Mihrshahi S. Exclusive breastfeeding and childhood morbidity: A narrative review. Int J Environ Res Public Health. 2022;19(22):14804.
Atyeo C, Alter G. The multifaceted roles of breast milk antibodies. Cell. 2021;184(6):1486–99.
Camacho-Morales A, Caba M, García-Juárez M, Caba-Flores MD, Viveros-Contreras R, Martínez-Valenzuela C. Breastfeeding contributes to physiological immune programming in the newborn. Front Pead. 2021;9:744104.
He Y, Lawlor NT, Newburg DS. Human milk components modulate toll-like receptor–mediated inflammation. Adv Nutr. 2016;7(1):102–11.
Bernardo H, Cesar V, World Health Organization. &. (2013). Long-term effects of breastfeeding: A systematic review. World Health Organ. https://iris.who.int/handle/10665/79198
Harvey SM, Murphy VE, Whalen OM, Gibson PG, Jensen ME. Breastfeeding and wheeze-related outcomes in high-risk infants: A systematic review and meta-analysis. Am J Clin Nutr. 2021;113(6):1609–18.
Lamberti LM, Zakarija-Grković I, Fischer Walker CL, Theodoratou E, Nair H, Campbell H, et al. Breastfeeding for reducing the risk of pneumonia morbidity and mortality in children under two: A systematic literature review and meta-analysis. BMC Public Health. 2013;13(Suppl 3):S18.
Karmany PAW, Rahardjo SS, Murti B. The effects of non-exclusive breastfeeding on the risk of pneumonia in children under five: Meta-analysis. J Epidemiol Public Health. 2020;5(4):393–401.
Alamneh YM, Adane F. Magnitude and predictors of pneumonia among under-five children in Ethiopia: A systematic review and meta-analysis. J Environ Public Health. 2020;2020:1–9.
Beletew B, Bimerew M, Mengesha A, Wudu M, Azmeraw M. Prevalence of pneumonia and its associated factors among under-five children in East Africa: A systematic review and meta-analysis. BMC Pediatr. 2020;20:254.
Brew BK, Allen CW, Toelle BG, Marks GB. Systematic review and meta-analysis investigating breastfeeding and childhood wheezing illness. Paediatr Perinat Epidemiol. 2011;25:507–18.
Lodge CJ, Tan D, Lau M, Dai X, Tham R, Lowe AJ, Bowatte G, Allen K, Dharmage SC. Breastfeeding and asthma and allergies: A systematic review and meta-analysis. Acta Paediatr. 2015;104:38–53.
Dogaru CM, Nyffenegger D, Pescatore AM, Spycher BD, Kuehni CE. Breastfeeding and childhood asthma: A systematic review and meta-analysis. Am J Epidemiol. 2014;179:1153–67.
Gdalevich M, Mimouni D, Mimouni M. Breast-feeding and the risk of bronchial asthma in childhood: A systematic review with meta-analysis of prospective studies. J Pediatr. 2001;139:261–6.
Moher D, Liberati A, Tetzlaff J, Altman DG, Group PRISMA. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009;151:264–9.
Booth A, Clarke M, Dooley G, Ghersi D, Moher D, Petticrew M, Stewart L. The nuts and bolts of PROSPERO: an international prospective register of systematic reviews. Syst Reviews. 2012;1:1–9.
Gates M, Gates A, Pieper D, Fernandes RM, Tricco AC, Moher D, Brennan SE, Li T, Pollock M, Lunny C. Reporting guideline for overviews of reviews of healthcare interventions: development of the PRIOR statement. BMJ 2022, 378.
Shea BJ, Reeves BC, Wells G, Thuku M, Hamel C, Moran J, Moher D, Tugwell P, Welch V, Kristjansson E. AMSTAR 2: A critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both. BMJ 2017, 358.
Shea BJ, Grimshaw JM, Wells GA, Boers M, Andersson N, Hamel C, Porter AC, Tugwell P, Moher D, Bouter LM. Development of AMSTAR: A measurement tool to assess the methodological quality of systematic reviews. BMC Med Res Methodol. 2007;7:10.
Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21:1539–58.
Ioannidis JP. Interpretation of tests of heterogeneity and bias in meta-analysis. J Eval Clin Pract. 2008;14:951–7.
Egger M, Smith GD, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629–34.
Belbasis L, Bellou V, Evangelou E, Ioannidis JP, Tzoulaki I. Environmental risk factors and multiple sclerosis: an umbrella review of systematic reviews and meta-analyses. Lancet Neurol. 2015;14(3):263–73.
Xue M, Dehaas E, Chaudhary N, O’Byrne P, Satia I, Kurmi OP. Breastfeeding and risk of childhood asthma: a systematic review and meta-analysis. Eur Respiratory J Open Res. 2021;7(4):e00394–2021.
World Health Organization. Exclusive breastfeeding for optimal growth, development, and health of infants. World Health Organization; 2023.
Centers for Disease Control and Prevention. Infant and toddler nutrition. Centers for Disease Control and Prevention. 2023. Available from: https://www.cdc.gov/infant-toddler-nutrition/about/index.html
Lamberti LM, Zakarija-Grković I, Fischer Walker CL, Theodoratou E, Nair H, Campbell H, Black RE. Breastfeeding for reducing the risk of pneumonia morbidity and mortality in children under two: a systematic literature review and meta-analysis. BMC Public Health. 2013;13(Suppl 3):S18.
Kaur A, Singh K, Pannu MS, Singh P, Sehgal N, Kaur R. The effect of exclusive breastfeeding on hospital stay and morbidity due to various diseases in infants under 6 months of age: a prospective observational study. Int J Pediatr Adolesc Med. 2016;2016:7647054.
Ladomenou F, Moschandreas J, Kafatos A, Tselentis Y, Galanakis E. Protective effect of exclusive breastfeeding against infections during infancy: a prospective study. Arch Dis Child. 2010;95(12):1004–8.
Mineva GM, Purtill H, Dunne CP, Philip RK. Impact of breastfeeding on the incidence and severity of respiratory syncytial virus (RSV)-associated acute lower respiratory infections in infants: a systematic review highlighting the global relevance of primary prevention. BMJ Global Health. 2023;8(2):e009693.
Boccolini CS, Carvalho MLd O, MICd, Boccolini PdMM. Breastfeeding can prevent hospitalization for pneumonia among children under 1 year old. J Pediatr. 2011;87:399–404.
Bachrach VRG, Schwarz E, Bachrach LR. Breastfeeding and the risk of hospitalization for respiratory disease in infancy: a meta-analysis. Arch Pediatr Adolesc Med. 2003;157(3):237–43.
Dizon-Ditangco VAL, Abiog-castro R. Exclusive breastfeeding from birth to 6 months for reducing community acquired pneumonia in children up to 5 years of age: A systematic review and meta-analysis. Pediatr Infect Disease Soc Philippines J. 2020;21(2):13–23.
Lokossou GA, Kouakanou L, Schumacher A, Zenclussen AC. Human breast milk: from food to active immune response with disease protection in infants and mothers. Front Immunol. 2022;13:849012.
Lönnerdal B. Bioactive proteins in breast milk. J Paediatr Child Health. 2013;49(1):1–7.
Miliku K, Azad MB. Breastfeeding and the developmental origins of asthma: current evidence, possible mechanisms, and future research priorities. Nutrients. 2018;10(8):995.
Vassilopoulou E, Agostoni C, Feketea G, Alberti I, Gianni ML, Milani GP. The role of breastfeeding in acute respiratory infections in infancy. Pediatr Infect Dis J. 2024;43(11):1090–9.
Quitadamo PA, Comegna L, Cristalli P. Anti-infective, anti-inflammatory, and Immunomodulatory properties of breast milk factors for the protection of infants in the pandemic from COVID-19. Front Public Health. 2021;8:589736.
Ho NT, Li F, Lee-Sarwar KA, Tun HM, Brown BP, Pannaraj PS, Bender JM, Azad MB, Thompson AL, Weiss ST. Meta-analysis of effects of exclusive breastfeeding on infant gut microbiota across populations. Nat Commun. 2018;9(1):4169.
Davis EC, Castagna VP, Sela DA, Hillard MA, Lindberg S, Mantis NJ, Seppo AE, Järvinen KM. Gut Microbiome and breast-feeding: implications for early immune development. J Allergy Clin Immunol. 2022;150(3):523–34.
Kornides M, Kitsantas P. Evaluation of breastfeeding promotion, support, and knowledge of benefits on breastfeeding outcomes. J Child Health Care. 2013;17(3):264–73.
Ciampo LAD, Ciampo IRLD. Breastfeeding and the benefits of lactation for women’s health. Revista Brasileira De Ginecol E Obstetrícia. 2018;40:354–9.
Flohr C, Nagel G, Weinmayr G, Kleiner A, Strachan D, Williams H, Group IPTS. Lack of evidence for a protective effect of prolonged breastfeeding on childhood eczema: lessons from the international study of asthma and allergies in childhood (ISAAC) phase two. Br J Dermatol. 2011;165(6):1280–9.
Berlanga-Macías C, Álvarez-Bueno C, Martínez-Hortelano JA, Garrido-Miguel M, Pozuelo-Carrascosa DP, Martínez-Vizcaíno V. Relationship between exclusive breastfeeding and cardiorespiratory fitness in children and adolescents: a meta-analysis. Scand J Med Sci Sports. 2020;30(5):828–36.
García-Hermoso A, Ramírez-Vélez R, García-Alonso Y, Alonso-Martínez AM, Izquierdo M. Association of cardiorespiratory fitness levels during youth with health risk later in life: a systematic review and meta-analysis. JAMA Pediatr. 2020;174(10):952–60.
Acknowledgements
N/A.
Funding
There was no funding source for this study.
Author information
Authors and Affiliations
Contributions
Conceptualization: Biruk Beletew Abate, Freweyni Gebreegziabher Araya, Getachew Tesfaw, Tegene Atamenta Kitaw, Amare Kassaw, Ayelign Mengesha Kassie, Gizachew Yilak, Fasikaw Kebede, Molla Azmeraw Bizuayehu. Data curation: Biruk Beletew Abate, Biruk Shalmeno Tusa, Ashenafi Kibret Sendekie, Alemu Birara Zemariam, Amare Kassaw, Ayelign Mengesha Kassie, Gizachew Yilak, Fasikaw Kebede, Molla Azmeraw Bizuayehu, Berihun Dachew. Formal analysis, validation, and visualization: Biruk Beletew Abate, Biruk Shalmeno Tusa, Ashenafi Kibret Sendekie, Freweyni Gebreegziabher Araya, Ayelign Mengesha Kassie, Gizachew Yilak, Fasikaw Kebede, Molla Azmeraw Bizuayehu, Berihun Dachew. Writing– original draft: Biruk Beletew Abate, Biruk Shalmeno Tusa, Ashenafi Kibret Sendekie, Freweyni Gebreegziabher Araya, Getachew Tesfaw, Tegene Atamenta Kitaw, Befkad Derese Tilahun, Addis Wondmagegn Alamaw, Alemu Birara Zemariam, Amare Kassaw, Ayelign Mengesha Kassie, Gizachew Yilak, Fasikaw Kebede, Molla Azmeraw Bizuayehu, Berihun Dachew. Writing– review & editing: Biruk Beletew Abate, Biruk Shalmeno Tusa, Ashenafi Kibret Sendekie, Freweyni Gebreegziabher Araya, Getachew Tesfaw, Tegene Atamenta Kitaw, Befkad Derese Tilahun, Addis Wondmagegn Alamaw, Alemu Birara Zemariam, Amare Kassaw, Ayelign Mengesha Kassie, Gizachew Yilak, Fasikaw Kebede, Molla Azmeraw Bizuayehu, Berihun Dachew.
Corresponding author
Ethics declarations
Ethics approval and consent to participate
Not applicable.
Consent for publication
Not applicable.
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
13006_2025_712_MOESM1_ESM.docx
Additional files: Supplementary Table 1: Shows quality appraisal of included SRM using AMSTAR-2 checklist. Supplementary Table 2: Quality assessment using the GRADE framework of each pooled analysis assessing associations Between non-exclusive breastfeeding and the risk of pneumonia and asthma. Supplementary Figure 1: Funnel plot on the pooled exclusive breastfeeding for the prevention of respiratory problems. Supplementary Figure 2: Publication bias on the pooled exclusive breastfeeding for the prevention of respiratory problems. Supplementary Figure 3: Trim-and-fill analysis on the pooled exclusive breastfeeding for the prevention of pneumonia and asthma
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.
About this article
Cite this article
Abate, B.B., Tusa, B.S., Sendekie, A.K. et al. Non-exclusive breastfeeding is associated with pneumonia and asthma in under-five children: an umbrella review of systematic review and meta-analysis. Int Breastfeed J 20, 18 (2025). https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s13006-025-00712-w
Received:
Accepted:
Published:
DOI: https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s13006-025-00712-w